Laura Lynne Stockton

Array ( [id] => 9216485 [patent_doc_number] => 08629285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Imidazole compounds that modulate HSP90 activity' [patent_app_type] => utility [patent_app_number] => 11/502347 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43033 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11502347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107792 [patent_doc_number] => 20070066670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Substituted benzimidazoles and their use for inducing apoptosis' [patent_app_type] => utility [patent_app_number] => 11/501648 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14617 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066670.pdf [firstpage_image] =>[orig_patent_app_number] => 11501648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228935 [patent_doc_number] => 07601748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Anti-androgenic pyrrolidines with tumor-inhibiting action' [patent_app_type] => utility [patent_app_number] => 11/500876 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18284 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601748.pdf [firstpage_image] =>[orig_patent_app_number] => 11500876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890168 [patent_doc_number] => 20060276526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Crystalline Form of Telmisartan Sodium' [patent_app_type] => utility [patent_app_number] => 11/462531 [patent_app_country] => US [patent_app_date] => 2006-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4573 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276526.pdf [firstpage_image] =>[orig_patent_app_number] => 11462531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263831 [patent_doc_number] => 07569596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Imidazolamino compounds' [patent_app_type] => utility [patent_app_number] => 11/494917 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6197 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569596.pdf [firstpage_image] =>[orig_patent_app_number] => 11494917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625957 [patent_doc_number] => 20060264462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Imidazolamino compounds' [patent_app_type] => utility [patent_app_number] => 11/495044 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6171 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264462.pdf [firstpage_image] =>[orig_patent_app_number] => 11495044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 373481 [patent_doc_number] => 07473784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => 'Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/494234 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22156 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473784.pdf [firstpage_image] =>[orig_patent_app_number] => 11494234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823253 [patent_doc_number] => 20080227783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => '5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/996743 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13832 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227783.pdf [firstpage_image] =>[orig_patent_app_number] => 11996743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142574 [patent_doc_number] => 20070004790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Nonsedating Alpha-2 Agonists' [patent_app_type] => utility [patent_app_number] => 11/458731 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10218 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004790.pdf [firstpage_image] =>[orig_patent_app_number] => 11458731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279237 [patent_doc_number] => 20090131369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Novel Benzimidazole(Thio)Carbamates with Antiparasitic Activity and the Synthesis Thereof' [patent_app_type] => utility [patent_app_number] => 11/997057 [patent_app_country] => US [patent_app_date] => 2006-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8437 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131369.pdf [firstpage_image] =>[orig_patent_app_number] => 11997057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316500 [patent_doc_number] => 20090281098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'BENZOIMIDAZOLE COMPOUND CAPABLE OF INHIBITING PROSTAGLANDIN D SYNTHETASE' [patent_app_type] => utility [patent_app_number] => 11/995437 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29061 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281098.pdf [firstpage_image] =>[orig_patent_app_number] => 11995437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7997641 [patent_doc_number] => 08080668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => 'Thiazoles derivatives as AMPK activator' [patent_app_type] => utility [patent_app_number] => 11/480032 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10010 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080668.pdf [firstpage_image] =>[orig_patent_app_number] => 11480032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698904 [patent_doc_number] => 20080221088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => '3,4-Substituted Thiazoles as Ampk Activators' [patent_app_type] => utility [patent_app_number] => 11/917229 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9799 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221088.pdf [firstpage_image] =>[orig_patent_app_number] => 11917229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272330 [patent_doc_number] => 20090076106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => '2-(Phenylamino) Benzimidazole Derivatives and Their Use as Modulators of Small- Conductance Calcuim-Activated Potassium Channels' [patent_app_type] => utility [patent_app_number] => 11/919708 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5956 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076106.pdf [firstpage_image] =>[orig_patent_app_number] => 11919708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 571553 [patent_doc_number] => 07462723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Imidazolamino compounds' [patent_app_type] => utility [patent_app_number] => 11/472064 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6199 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462723.pdf [firstpage_image] =>[orig_patent_app_number] => 11472064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177705 [patent_doc_number] => 08178694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Heterocyclylaminoalkyl substituted benzimidazoles' [patent_app_type] => utility [patent_app_number] => 11/993126 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10149 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178694.pdf [firstpage_image] =>[orig_patent_app_number] => 11993126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840369 [patent_doc_number] => 20080280855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Process For the Production of Intermediates For the Preparation of Tricyclic Benzimidazoles' [patent_app_type] => utility [patent_app_number] => 11/922213 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50237 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280855.pdf [firstpage_image] =>[orig_patent_app_number] => 11922213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5603029 [patent_doc_number] => 20060293374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Substituted isothiazolones' [patent_app_type] => utility [patent_app_number] => 11/453382 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14368 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293374.pdf [firstpage_image] =>[orig_patent_app_number] => 11453382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142430 [patent_doc_number] => 20070004646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/450959 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31937 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004646.pdf [firstpage_image] =>[orig_patent_app_number] => 11450959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625986 [patent_doc_number] => 20060264491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Telmisartan production process' [patent_app_type] => utility [patent_app_number] => 11/449087 [patent_app_country] => US [patent_app_date] => 2006-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2615 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264491.pdf [firstpage_image] =>[orig_patent_app_number] => 11449087 [rel_patent_id] =>[rel_patent_doc_number] =>)